Digital droplet PCR at the time of TKI discontinuation in chronic-phase chronic myeloid leukemia patients is predictive of treatment-free remission outcome

Colafigli Gioia; Scalzulli Emilia; Porrazzo Marika; Diverio Daniela; Loglisci Maria Giovanna; Latagliata Roberto; Guarini Anna; Foa Robin; Breccia Massimo

首页> 外文期刊>Hematological oncology >Digital droplet PCR at the time of TKI discontinuation in chronic-phase chronic myeloid leukemia patients is predictive of treatment-free remission outcome

【24h】

Digital droplet PCR at the time of TKI discontinuation in chronic-phase chronic myeloid leukemia patients is predictive of treatment-free remission outcome

机译：TKI停止时的数字液滴PCR在慢性相慢性骨髓白血病患者的预测性免除抗缓解结果

获取原文

获取原文并翻译 | 示例

掌桥外文数据库（机构版） >>

开具论文收录证明 >>

文献代查 >>

页面导航

著录项
相似文献
相关主题

著录项

来源
《Hematological oncology》 |2019年第5期|共3页
作者
Colafigli Gioia; Scalzulli Emilia; Porrazzo Marika; Diverio Daniela; Loglisci Maria Giovanna; Latagliata Roberto; Guarini Anna; Foa Robin; Breccia Massimo;
展开▼
作者单位

Univ Sapienza Dept Translat &

Precis Med Hematol Rome Italy;

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类肿瘤学;
关键词

相似文献

外文文献
中文文献
专利

1. 用马利兰、环磷酰胺、足叶乙甙为预处理方案对急性髓系白血病患者异基因骨髓移植治疗第一次完全缓解时的高剂量化疗 [J] . 祁明芳, 郁知非中德临床肿瘤学杂志（英文版） . 2000,第001期
2. Digital droplet PCR at the time of TKI discontinuation in chronic-phase chronic myeloid leukemia patients is predictive of treatment-free remission outcome [J] . Colafigli Gioia, Scalzulli Emilia, Porrazzo Marika, Hematological oncology . 2019,第S2期

机译：TKI停止时的数字液滴PCR在慢性相慢性骨髓白血病患者的预测性免除抗缓解结果
3. Comparative Monitoring of Minimal Residual Disease (MRD) By RT-Quantitative (RT-qPCR) and Digital PCR (dPCR) in Ph plus Chronic Myeloid Leukemia (CML) Patients Treated with TKIs for Recognition of Stable Deep Molecular Response (DMR) and Identification of Best Candidates to TKIs Treatment Discontinuation [J] . Bernardi Simona, Malagola Michele, Zanaglio Camilla, Blood: The Journal of the American Society of Hematology . 2018,第NovaelaTreatmentAppr期

机译：对RT-定量（RT-QPCR）的最小残留疾病（MRD）的比较监测pH加慢性骨髓白血病（CML）治疗TKIS治疗稳定深度分子反应（DMR）和鉴定 TKIS治疗中止的最佳候选人
4. Deeper molecular response is a predictive factor for treatment-free remission after imatinib discontinuation in patients with chronic phase chronic myeloid leukemia: the JALSG-STIM213 study [J] . Takahashi Naoto, Tauchi Tetsuzo, Kitamura Kunio, International journal of hematology . 2018,第2期

机译：更深层次的分子反应是慢性期慢性骨髓白血病患者的伊马替尼停止后的无治疗缓解的预测因素：JALSG-STIM213研究
5. Identification of Platelet Factor-4 as an Indicator of Blood Count Recovery in Acute Myeloid Leukemia Patients in Complete Remission [C] . Jin Young Kim, Ho-Jun Song, Hoi-Jeong Lim, ASMS Conference on Mass Spectrometry and Allied Topics . 2008

机译：血小板因子-4的鉴定为急性髓性白血病患者血统恢复的指标完全缓解
6. High-avidity PR1-specific CD8+ lymphocytes contribute to the maintenance of remission in patients with myeloid leukemia. [D] . Kant, Shreya. 2005

机译：PR1特异性高CD8 +淋巴细胞有助于维持骨髓性白血病患者的缓解。
7. Residual Peripheral Blood CD26+ Leukemic Stem Cells in Chronic Myeloid Leukemia Patients During TKI Therapy and During Treatment-Free Remission [O] . Monica Bocchia, Anna Sicuranza, Elisabetta Abruzzese, 2018

机译：TKI治疗期间和无治疗期缓解期间慢性粒细胞白血病患者的外周血CD26 +白血病干细胞残留
8. Identification of Immunological Parameters as Predictive Biomarkers of Relapse in Patients with Chronic Myeloid Leukemia on Treatment-Free Remission [O] . Lorena Vigón, Alejandro Luna, Miguel Galán, 2020

机译：鉴定免疫参数作为慢性骨髓白血病患者复发的预测生物标志物治疗免疫

Digital droplet PCR at the time of TKI discontinuation in chronic-phase chronic myeloid leukemia patients is predictive of treatment-free remission outcome

著录项

相似文献

相关主题

期刊订阅